Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Clinical trial NCT00978627 · COMPLETED

Trial details

NCT number: NCT00978627
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 1

Start date: 2009-08-01
Primary completion: 2010-05-01
Enrollment: 548

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.